The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritis: Fig. 1
Abstract
No abstract available
Cédric Para : Connect in order to contact the contributor
https://inserm.hal.science/inserm-04171983
Submitted on : Friday, April 12, 2024-3:25:00 PM
Last modification on : Wednesday, May 15, 2024-2:22:03 PM